Clinical Trials
All Clinical Trials - Page 47 of 52
A complete, crawlable index of every tracked clinical trial of peptide compounds. Use the search browser at /trials for filtering, or page through the full list here.
- NCT00528866Phase 2Completed
Radiation Therapy, Androgen Suppression, and Docetaxel in Treating Patients With High-Risk Prostate Cancer Who Have Undergone Radical Prostatectomy
Gonadorelin
- NCT00664456Phase 3Completed
Luteinizing Hormone-Releasing Hormone Agonist Therapy and Iodine I 125 Implant in Treating Patients With Previously Untreated Prostate Cancer
Gonadorelin
- NCT00851461Phase 4Completed
Effect of Goserelin (Zoladex®) in Spinal and Bulbar Muscular Atrophy
Gonadorelin
- NCT00630825Phase 2Completed
A Study of Dose Titration of LY2189265 in Overweight Participants With Type 2 Diabetes Mellitus
Dulaglutide
- NCT00672399Phase 1Completed
Electrophysiological Effects of a Single 10 μg Dose of Exenatide on the 12-Lead Electrocardiogram QT Interval in Healthy Subjects
Exenatide
- NCT01154933Phase 2Completed
Exeantide in Type 2 Diabetes on Insulin
Exenatide
- NCT00806520N/ACompleted
Use of Continuous Glucose Monitoring Combined With Ambulatory Glucose Profiles to Characterize Glycemic Control
Exenatide
- NCT00641056Phase 3Completed
Efficacy of Exenatide Once Weekly and Once-Daily Insulin Glargine in Patients With Type 2 Diabetes Treated With Metformin Alone or in Combination With Sulfonylurea (DURATION - 3)
Exenatide
- NCT01076842Phase 4Completed
Efficacy Evaluation of Different Medication Combination in Type 2 Diabetes Treatment
Exenatide
- NCT01125488Phase 3Unknown
Maintenance Therapy of Levonorgestrel-releasing Intrauterine System (LNG-IUS) to Prevent the Recurrence of Symptomatic Endometriosis After Conservative Surgery
Gonadorelin
- NCT00631527Phase 1Completed
Sunitinib Malate, Hormone Ablation and Radiation Therapy in Patients With Prostate Cancer
Gonadorelin
- NCT00620282Phase 3Completed
The Effect of Liraglutide on Endothelial Function in Subjects With Type 2 Diabetes Mellitus
Liraglutide
- NCT00642538Phase 1Completed
A Study Designed to Determine the Safety and Pharmacological Response ofMKC253 Inhalation Powder in Adults With Type 2 Diabetes Mellitus
Exenatide
- NCT01435980Phase 4Unknown
Study of Comparison the Treatment Effect Between Gastric Bypass and Exenatide in Type 2 Diabetes
Exenatide
- NCT01021527Phase 1Completed
A Study to Assess the Effects of Exenatide on Insulin Secretion Rates Using a Graded Infusion of Intravenous Glucose (0000-099)(COMPLETED)
Exenatide
- NCT00622323N/ACompleted
Post Marketing Surveillance Study of Byetta ™ (Exenatide) Use Among Filipino Patients
Exenatide
- NCT00593853Phase 2Terminated
Efficacy Study of Methylphenidate Hydrochloride to Reduce Fatigue in Prostate Cancer Patients Receiving Hormone Therapy
Gonadorelin
- NCT00614120Phase 3Completed
Effect of Liraglutide or Glimepiride Added to Metformin on Blood Glucose Control in Subjects With Type 2 Diabetes
Liraglutide
- NCT00971659Phase 1Completed
Adjunctive Therapy of Exenatide or Sitagliptin to Insulin Glargine in Type 2 Diabetes
Exenatide
- NCT00637273Phase 3Completed
A Study to Compare the Glycemic Effects, Safety, and Tolerability of Exenatide Once Weekly to Those of Sitagliptin and Pioglitazone,in Subjects With Type 2 Diabetes Treated With Metformin (DURATION - 2)
Exenatide
- NCT00635492N/ACompleted
CHOICE: CHanges to Treatment and Outcomes in Patients With Type 2 Diabetes Initiating InjeCtablE Therapy
Exenatide
- NCT00603239Phase 3Completed
Safety and Efficacy of Exenatide in Patients With Type 2 Diabetes Using a Thiazolidinedione or a Thiazolidinedione and Metformin
Exenatide
- NCT01006889Phase 4Completed
Adding Exenatide to Insulin Therapy for Patients With Type 2 Diabetes and Non-Alcoholic Fatty Liver Disease
Exenatide
- NCT00577824Phase 3Completed
Efficacy and Safety of Exenatide in Japanese Patients With Type 2 Diabetes Who Are Treated With Oral Antidiabetic(s)
Exenatide
- NCT00623545Phase 4Completed
Bioenergetic Alterations After Exenatide Administration
Exenatide
- NCT00807365Phase 2Terminated
Six Month Treatment of Growth Hormone Releasing Hormone (GHRH) in the Elderly
Sermorelin
- NCT00598871Phase 2Terminated
A Phase 2 Study of the Safety and Efficacy of Thymosin Beta 4 for Treating Corneal Wounds
TB-500
- NCT00580450Phase 1/Phase 2Unknown
Thymosin Alfa 1 in Recipients of Allogeneic Hematopoietic Transplantation for Hematological Malignancies
Thymosin-Alpha-1
- NCT00829192Phase 2Unknown
Phase II AK Study in Organ Transplant Patients
Afamelanotide
- NCT00571870N/ACompleted
Gonadotropin-releasing Hormone Antagonist on Triggering Day: A Randomized Controlled Study
Gonadorelin
- NCT00560417Phase 3Completed
Comparison of Two Basal Insulins for Patients With Type 2 Diabetes Taking Oral Diabetes Medicines and Exenatide
Exenatide
- NCT00937079N/ACompleted
Whole Body 111In-exendin-4 Imaging Study in Insulinoma Patients
Exenatide
- NCT02084654Phase 1Completed
Exenatide and Weight Loss for Diabetes Prevention
Exenatide
- NCT00564850Phase 3Completed
Efficacy and Safety Study of Pamoate of Triptorelin in Children With Precocious Puberty
Gonadorelin
- NCT00527488Phase 2Completed
Explorative Study of Degarelix for Treatment of Benign Prostatic Hyperplasia.
Gonadorelin
- NCT00551343N/ACompleted
Gut Derived Hormones, Body Composition and Metabolism in Prader-Willi Syndrome
Exenatide
- NCT00546728Phase 4Completed
The Vascular Effects of Exenatide Versus Metformin in Patients With Pre-Diabetes
Exenatide
- NCT00529204Phase 2Terminated
Effects Of Exenatide On Liver Biochemistry, Liver Histology And Lipid Metabolism In Patients With Fatty Liver Disease
Exenatide
- NCT00679042Phase 3Active Not Recruiting
Islet Transplantation in Type 1 Diabetic Patients Using the University of Illinois at Chicago (UIC) Protocol
Exenatide
- NCT00512668Phase 1Terminated
Hormone Therapy and Temsirolimus in Treating Patients With Relapsed Prostate Cancer
Gonadorelin
- NCT00612794Phase 1Completed
A Study to Examine Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Exenatide Once Weekly in Japanese Patients With Type 2 Diabetes
Exenatide
- NCT00516074Phase 3Completed
A Study to Assess the Effect of Exenatide Treatment on Mean 24-Hour Heart Rate in Patients With Type 2 Diabetes
Exenatide
- NCT00608023Phase 3Completed
TH9507 Extension Study in Patients With HIV-Associated Lipodystrophy
Tesamorelin
- NCT00603109Phase 3Terminated
Effect of Rimonabant on Weight Gain and Body Composition in Adults With Prader Willi Syndrome
Ghrp-6
- NCT00521781Phase 2Terminated
Study of Abraxane Plus Hormonal Therapy as Initial Treatment of Unresectable or Metastatic Prostate Cancer
Gonadorelin
- NCT00508287Phase 1Completed
Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of BMS-686117 in Subjects With Type 2 Diabetes
Exenatide
- NCT00516048Phase 3Completed
An Exploratory Study of the Effect of Treatment Interruption on Safety of Exenatide in Patients With Type 2 Diabetes
Exenatide
- NCT00518882Phase 3Completed
Effect of Liraglutide or Exenatide Added to an Ongoing Treatment on Blood Glucose Control in Subjects With Type 2 Diabetes
Liraglutide
- NCT00324064N/ACompleted
Sexually Dimorphic Effects of GHRH in Adult Growth Hormone Testing
Sermorelin
- NCT03144271Phase 1Completed
Dose Escalation Trial of Single Subcutaneous Doses of NNC 0113-0217 to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics in Healthy Male Subjects
Semaglutide